“DONANEMAB AND THE FUTURE OF ALZHEIMER’S TREATMENT: BETWEEN INNOVATION AND CAUTION”, IJITSS, vol. 3, no. 4(48), Dec. 2025, doi: 10.31435/ijitss.4(48).2025.4214.